A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-04

AUTHORS

Andrea Rocca, Roberta Maltoni, Alessandro Passardi, Ilaria Massa, Michele Aquilina, Ruggero Ridolfi, Toni Ibrahim, Lorenzo Cecconetto, Samanta Sarti, Elisabetta Pietri, Oriana Nanni, Dino Amadori

ABSTRACT

PURPOSE: Anthracyclines and fluoropyrimidines are very active in breast cancer, while liposomal doxorubicin has low cardiotoxicity. We conducted a dose-finding study of the combination of liposomal doxorubicin and capecitabine in patients with pretreated metastatic breast cancer. PATIENTS AND METHODS: Patients received liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2 bid (level 0) or 1,000 mg/m2 bid (level 1) on days 1-14 of each 21-day cycle to establish the maximum tolerated dose (MTD) and cardiac safety. RESULTS: Nine patients were enrolled and a total of 52 courses were delivered (median 6 cycles per patient [range 4-7]). Grade 4 neutropenia occurred in 15% of cycles, with one episode of febrile neutropenia; most nonhematological toxicities were mild or moderate. No formal MTD was established, and the study was closed because two cardiac events were observed at dose level 1 and another at dose level 0 in patients pretreated with epirubicin > or = 560 mg/m2. CONCLUSIONS: The recommended dose for phase II studies is liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2/bid on days 1-14 of each 21-day cycle. Despite the lower cardiotoxicity of liposomal doxorubicin, the risk of cardiac damage persists in anthracycline-pretreated individuals and mandates close cardiac monitoring and careful evaluation of the overall cumulative dose. More... »

PAGES

871-876

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-009-1092-8

DOI

http://dx.doi.org/10.1007/s00280-009-1092-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039240349

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19693503


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Maximum Tolerated Dose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rocca", 
        "givenName": "Andrea", 
        "id": "sg:person.01267331536.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267331536.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maltoni", 
        "givenName": "Roberta", 
        "id": "sg:person.01230204125.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230204125.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Passardi", 
        "givenName": "Alessandro", 
        "id": "sg:person.0650341574.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650341574.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Biostatistics Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Massa", 
        "givenName": "Ilaria", 
        "id": "sg:person.01317711041.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317711041.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiology Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aquilina", 
        "givenName": "Michele", 
        "id": "sg:person.01145631270.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145631270.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ridolfi", 
        "givenName": "Ruggero", 
        "id": "sg:person.01050453536.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ibrahim", 
        "givenName": "Toni", 
        "id": "sg:person.0620211740.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620211740.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cecconetto", 
        "givenName": "Lorenzo", 
        "id": "sg:person.01017475431.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017475431.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarti", 
        "givenName": "Samanta", 
        "id": "sg:person.0604566770.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604566770.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pietri", 
        "givenName": "Elisabetta", 
        "id": "sg:person.0604174261.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604174261.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Biostatistics Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nanni", 
        "givenName": "Oriana", 
        "id": "sg:person.01371010677.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371010677.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.419563.c", 
          "name": [
            "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amadori", 
        "givenName": "Dino", 
        "id": "sg:person.01253475476.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253475476.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6601634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000037654", 
          "https://doi.org/10.1038/sj.bjc.6601634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000037654", 
          "https://doi.org/10.1038/sj.bjc.6601634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-004-0825-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000242317", 
          "https://doi.org/10.1007/s00280-004-0825-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-004-0825-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000242317", 
          "https://doi.org/10.1007/s00280-004-0825-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djn206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011671344"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2005.03.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012876474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2005.03.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012876474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021874298"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2007.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028310797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038018521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038018521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200303000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039883876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200303000-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039883876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040155212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.9401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042840373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200504000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046502627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200504000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046502627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(03)00266-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051862072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(03)00266-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051862072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.5.1444", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074777253"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-04", 
    "datePublishedReg": "2010-04-01", 
    "description": "PURPOSE: Anthracyclines and fluoropyrimidines are very active in breast cancer, while liposomal doxorubicin has low cardiotoxicity. We conducted a dose-finding study of the combination of liposomal doxorubicin and capecitabine in patients with pretreated metastatic breast cancer.\nPATIENTS AND METHODS: Patients received liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2 bid (level 0) or 1,000 mg/m2 bid (level 1) on days 1-14 of each 21-day cycle to establish the maximum tolerated dose (MTD) and cardiac safety.\nRESULTS: Nine patients were enrolled and a total of 52 courses were delivered (median 6 cycles per patient [range 4-7]). Grade 4 neutropenia occurred in 15% of cycles, with one episode of febrile neutropenia; most nonhematological toxicities were mild or moderate. No formal MTD was established, and the study was closed because two cardiac events were observed at dose level 1 and another at dose level 0 in patients pretreated with epirubicin > or = 560 mg/m2.\nCONCLUSIONS: The recommended dose for phase II studies is liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2/bid on days 1-14 of each 21-day cycle. Despite the lower cardiotoxicity of liposomal doxorubicin, the risk of cardiac damage persists in anthracycline-pretreated individuals and mandates close cardiac monitoring and careful evaluation of the overall cumulative dose.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-009-1092-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "65"
      }
    ], 
    "name": "A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer", 
    "pagination": "871-876", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "baeb746f1de720e62162c26121f6ad7629d2f3f1a9a2009c59551d2c093a09bb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19693503"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-009-1092-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039240349"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-009-1092-8", 
      "https://app.dimensions.ai/details/publication/pub.1039240349"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13081_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00280-009-1092-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1092-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1092-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1092-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1092-8'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      21 PREDICATES      58 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-009-1092-8 schema:about N2e7c02b9cca149c08fbe4aa1bf2cf7b1
2 N3e16d16a493344cfa80989d12ae66c8b
3 N77481ec4d45c42f89dc63cadf6d9866d
4 N7e17525d995b462688dc6681846f7eb0
5 N85a4a437bde04c2f85118f50e511daf7
6 N8615f8fe8fab49f382cb181dede34106
7 N8cac85a3045045388f26178e3e18e5a7
8 Na4769e6ae1b745688f9996bdbb1758c7
9 Nb78eb14326cd479382bae1d35908c187
10 Nc3481be54d1d4d97b13c95c390477ae6
11 Nd451dd1c11b246b98b27106f28877514
12 Nfabd59dd52784a2d9b57b74402a47d8f
13 Nfdd8696316634e98b5852fbb2ba6499d
14 Nfe3394a44ab74b219a56a448215f007e
15 Nfffddd4582a14f5eb815d111a9035ef9
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N6625472a1de649edbe8a5e16f1d17455
19 schema:citation sg:pub.10.1007/s00280-004-0825-y
20 sg:pub.10.1038/sj.bjc.6601634
21 https://doi.org/10.1002/cncr.10201
22 https://doi.org/10.1002/cncr.11203
23 https://doi.org/10.1016/j.ejca.2005.03.027
24 https://doi.org/10.1016/j.ejca.2007.02.002
25 https://doi.org/10.1016/s0959-8049(03)00266-1
26 https://doi.org/10.1093/annonc/mdi308
27 https://doi.org/10.1093/jnci/92.3.205
28 https://doi.org/10.1093/jnci/djn206
29 https://doi.org/10.1097/00001813-200303000-00008
30 https://doi.org/10.1097/00001813-200504000-00011
31 https://doi.org/10.1200/jco.2001.19.5.1444
32 https://doi.org/10.1200/jco.2007.14.9401
33 schema:datePublished 2010-04
34 schema:datePublishedReg 2010-04-01
35 schema:description PURPOSE: Anthracyclines and fluoropyrimidines are very active in breast cancer, while liposomal doxorubicin has low cardiotoxicity. We conducted a dose-finding study of the combination of liposomal doxorubicin and capecitabine in patients with pretreated metastatic breast cancer. PATIENTS AND METHODS: Patients received liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2 bid (level 0) or 1,000 mg/m2 bid (level 1) on days 1-14 of each 21-day cycle to establish the maximum tolerated dose (MTD) and cardiac safety. RESULTS: Nine patients were enrolled and a total of 52 courses were delivered (median 6 cycles per patient [range 4-7]). Grade 4 neutropenia occurred in 15% of cycles, with one episode of febrile neutropenia; most nonhematological toxicities were mild or moderate. No formal MTD was established, and the study was closed because two cardiac events were observed at dose level 1 and another at dose level 0 in patients pretreated with epirubicin > or = 560 mg/m2. CONCLUSIONS: The recommended dose for phase II studies is liposomal doxorubicin 60 mg/m2 on day 1 plus capecitabine 825 mg/m2/bid on days 1-14 of each 21-day cycle. Despite the lower cardiotoxicity of liposomal doxorubicin, the risk of cardiac damage persists in anthracycline-pretreated individuals and mandates close cardiac monitoring and careful evaluation of the overall cumulative dose.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N239e13b2544648ae83d3b843bd5adeda
40 N41cb355c269c4342a035ea573e8dc1be
41 sg:journal.1088364
42 schema:name A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer
43 schema:pagination 871-876
44 schema:productId N5c4e3b1f0c6f40e68633ce0dbbc891f6
45 N7285ddb0755f4201a1fa7708c08b9b43
46 N7b1b5c54808b44328fe2e3125e787dce
47 Ncb14e0b4a76b4eb4b15921693587a2c0
48 Ncb2b67b059514d9cb80954732b173f45
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039240349
50 https://doi.org/10.1007/s00280-009-1092-8
51 schema:sdDatePublished 2019-04-11T14:28
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher Nc9871b5289b846b3aba643ed0b105346
54 schema:url http://link.springer.com/10.1007%2Fs00280-009-1092-8
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N00a7505eceb7452caf91e0fcf6f6658a rdf:first sg:person.01017475431.06
59 rdf:rest Nc9ff97bc51e4467089f0b3d86fa0319f
60 N07a5f835b4084b09993cc31281589260 rdf:first sg:person.01050453536.03
61 rdf:rest N14c55ac75e4a447585f4c1727f469bd2
62 N14c55ac75e4a447585f4c1727f469bd2 rdf:first sg:person.0620211740.11
63 rdf:rest N00a7505eceb7452caf91e0fcf6f6658a
64 N239e13b2544648ae83d3b843bd5adeda schema:volumeNumber 65
65 rdf:type schema:PublicationVolume
66 N2e7c02b9cca149c08fbe4aa1bf2cf7b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Fluorouracil
68 rdf:type schema:DefinedTerm
69 N3e16d16a493344cfa80989d12ae66c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Breast Neoplasms
71 rdf:type schema:DefinedTerm
72 N40f683303d7449fc874c7b10db8a5c63 rdf:first sg:person.0604174261.78
73 rdf:rest Nb496fb1a79a8414ebef7b36c3632bf02
74 N41cb355c269c4342a035ea573e8dc1be schema:issueNumber 5
75 rdf:type schema:PublicationIssue
76 N4e21e2e0e2f3400b830392f21797c145 rdf:first sg:person.0650341574.44
77 rdf:rest N56373debeb064828aede8fe533df65d4
78 N56373debeb064828aede8fe533df65d4 rdf:first sg:person.01317711041.26
79 rdf:rest N6c386831c6804978a625aeb445e79731
80 N5989eb9fa901434d84c0a364cf16d13f rdf:first sg:person.01230204125.56
81 rdf:rest N4e21e2e0e2f3400b830392f21797c145
82 N5c4e3b1f0c6f40e68633ce0dbbc891f6 schema:name dimensions_id
83 schema:value pub.1039240349
84 rdf:type schema:PropertyValue
85 N6625472a1de649edbe8a5e16f1d17455 rdf:first sg:person.01267331536.89
86 rdf:rest N5989eb9fa901434d84c0a364cf16d13f
87 N6c386831c6804978a625aeb445e79731 rdf:first sg:person.01145631270.26
88 rdf:rest N07a5f835b4084b09993cc31281589260
89 N7285ddb0755f4201a1fa7708c08b9b43 schema:name readcube_id
90 schema:value baeb746f1de720e62162c26121f6ad7629d2f3f1a9a2009c59551d2c093a09bb
91 rdf:type schema:PropertyValue
92 N77481ec4d45c42f89dc63cadf6d9866d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Dose-Response Relationship, Drug
94 rdf:type schema:DefinedTerm
95 N7b1b5c54808b44328fe2e3125e787dce schema:name nlm_unique_id
96 schema:value 7806519
97 rdf:type schema:PropertyValue
98 N7e17525d995b462688dc6681846f7eb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Deoxycytidine
100 rdf:type schema:DefinedTerm
101 N8121497b4d6d4e939218da55ad435218 rdf:first sg:person.01253475476.25
102 rdf:rest rdf:nil
103 N85a4a437bde04c2f85118f50e511daf7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Capecitabine
105 rdf:type schema:DefinedTerm
106 N8615f8fe8fab49f382cb181dede34106 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Aged
108 rdf:type schema:DefinedTerm
109 N898f51f5648d49a0a02e167240958778 schema:name Cardiology Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy
110 rdf:type schema:Organization
111 N8cac85a3045045388f26178e3e18e5a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Female
113 rdf:type schema:DefinedTerm
114 Na4769e6ae1b745688f9996bdbb1758c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Antineoplastic Combined Chemotherapy Protocols
116 rdf:type schema:DefinedTerm
117 Nb496fb1a79a8414ebef7b36c3632bf02 rdf:first sg:person.01371010677.02
118 rdf:rest N8121497b4d6d4e939218da55ad435218
119 Nb78eb14326cd479382bae1d35908c187 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Doxorubicin
121 rdf:type schema:DefinedTerm
122 Nc3481be54d1d4d97b13c95c390477ae6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Medication Adherence
124 rdf:type schema:DefinedTerm
125 Nc9871b5289b846b3aba643ed0b105346 schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 Nc9ff97bc51e4467089f0b3d86fa0319f rdf:first sg:person.0604566770.07
128 rdf:rest N40f683303d7449fc874c7b10db8a5c63
129 Ncb14e0b4a76b4eb4b15921693587a2c0 schema:name pubmed_id
130 schema:value 19693503
131 rdf:type schema:PropertyValue
132 Ncb2b67b059514d9cb80954732b173f45 schema:name doi
133 schema:value 10.1007/s00280-009-1092-8
134 rdf:type schema:PropertyValue
135 Nd1e9e86ee3d44614b9b75773fefab85e schema:name Biostatistics Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy
136 rdf:type schema:Organization
137 Nd451dd1c11b246b98b27106f28877514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Adult
139 rdf:type schema:DefinedTerm
140 Nfabd59dd52784a2d9b57b74402a47d8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Neoplasm Metastasis
142 rdf:type schema:DefinedTerm
143 Nfc01631c112a416a8344e741e7911c70 schema:name Biostatistics Unit, I.R.S.T., Via P. Maroncelli 40, 47014, Meldola, FC, Italy
144 rdf:type schema:Organization
145 Nfdd8696316634e98b5852fbb2ba6499d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Maximum Tolerated Dose
147 rdf:type schema:DefinedTerm
148 Nfe3394a44ab74b219a56a448215f007e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Humans
150 rdf:type schema:DefinedTerm
151 Nfffddd4582a14f5eb815d111a9035ef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1088364 schema:issn 0344-5704
161 1432-0843
162 schema:name Cancer Chemotherapy and Pharmacology
163 rdf:type schema:Periodical
164 sg:person.01017475431.06 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
165 schema:familyName Cecconetto
166 schema:givenName Lorenzo
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017475431.06
168 rdf:type schema:Person
169 sg:person.01050453536.03 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
170 schema:familyName Ridolfi
171 schema:givenName Ruggero
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050453536.03
173 rdf:type schema:Person
174 sg:person.01145631270.26 schema:affiliation N898f51f5648d49a0a02e167240958778
175 schema:familyName Aquilina
176 schema:givenName Michele
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145631270.26
178 rdf:type schema:Person
179 sg:person.01230204125.56 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
180 schema:familyName Maltoni
181 schema:givenName Roberta
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230204125.56
183 rdf:type schema:Person
184 sg:person.01253475476.25 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
185 schema:familyName Amadori
186 schema:givenName Dino
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253475476.25
188 rdf:type schema:Person
189 sg:person.01267331536.89 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
190 schema:familyName Rocca
191 schema:givenName Andrea
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267331536.89
193 rdf:type schema:Person
194 sg:person.01317711041.26 schema:affiliation Nd1e9e86ee3d44614b9b75773fefab85e
195 schema:familyName Massa
196 schema:givenName Ilaria
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317711041.26
198 rdf:type schema:Person
199 sg:person.01371010677.02 schema:affiliation Nfc01631c112a416a8344e741e7911c70
200 schema:familyName Nanni
201 schema:givenName Oriana
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371010677.02
203 rdf:type schema:Person
204 sg:person.0604174261.78 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
205 schema:familyName Pietri
206 schema:givenName Elisabetta
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604174261.78
208 rdf:type schema:Person
209 sg:person.0604566770.07 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
210 schema:familyName Sarti
211 schema:givenName Samanta
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604566770.07
213 rdf:type schema:Person
214 sg:person.0620211740.11 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
215 schema:familyName Ibrahim
216 schema:givenName Toni
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620211740.11
218 rdf:type schema:Person
219 sg:person.0650341574.44 schema:affiliation https://www.grid.ac/institutes/grid.419563.c
220 schema:familyName Passardi
221 schema:givenName Alessandro
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650341574.44
223 rdf:type schema:Person
224 sg:pub.10.1007/s00280-004-0825-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1000242317
225 https://doi.org/10.1007/s00280-004-0825-y
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/sj.bjc.6601634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000037654
228 https://doi.org/10.1038/sj.bjc.6601634
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1002/cncr.10201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021874298
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1002/cncr.11203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040155212
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/j.ejca.2005.03.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012876474
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/j.ejca.2007.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028310797
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0959-8049(03)00266-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051862072
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1093/annonc/mdi308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038018521
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1093/jnci/djn206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011671344
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1097/00001813-200303000-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039883876
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1097/00001813-200504000-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046502627
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2001.19.5.1444 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074777253
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.2007.14.9401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042840373
253 rdf:type schema:CreativeWork
254 https://www.grid.ac/institutes/grid.419563.c schema:alternateName Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
255 schema:name Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via P. Maroncelli 40, 47014, Meldola, FC, Italy
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...